While preclinical data on the peptide BPC-157 reveals profound therapeutic potential, clinicians are left navigating a landscape where robust human trials are conspicuously absent
Our compounds are not approved for human consumption, medical use, veterinary use, diagnostic purposes, or any form of therapeutic application
Join Waitlist Enter your email address to be notified when this item is back in stock
Recalls & Warnings April 06, 2026 Jamieson Joint Pain, Magnesium, and Maca Supplements Recalled On April 1, 2026, Health Canada (the Canadian equivalent of the FDA) announced that Jamieson Laboratories recalled certain Jamieson Joint Pain Relief, Magnesium Bisglycinate, and Maca supplements due to defective tamper-evident seals